» Articles » PMID: 22179058

Gi-biased β2AR Signaling Links GRK2 Upregulation to Heart Failure

Abstract

Rationale: Phosphorylation of β(2)-adrenergic receptor (β(2)AR) by a family of serine/threonine kinases known as G protein-coupled receptor kinase (GRK) and protein kinase A (PKA) is a critical determinant of cardiac function. Upregulation of G protein-coupled receptor kinase 2 (GRK2) is a well-established causal factor of heart failure, but the underlying mechanism is poorly understood.

Objective: We sought to determine the relative contribution of PKA- and GRK-mediated phosphorylation of β(2)AR to the receptor coupling to G(i) signaling that attenuates cardiac reserve and contributes to the pathogenesis of heart failure in response to pressure overload.

Methods And Results: Overexpression of GRK2 led to a G(i)-dependent decrease of contractile response to βAR stimulation in cultured mouse cardiomyocytes and in vivo. Importantly, cardiac-specific transgenic overexpression of a mutant β(2)AR lacking PKA phosphorylation sites (PKA-TG) but not the wild-type β(2)AR (WT-TG) or a mutant β(2)AR lacking GRK sites (GRK-TG) led to exaggerated cardiac response to pressure overload, as manifested by markedly exacerbated cardiac maladaptive remodeling and failure and early mortality. Furthermore, inhibition of G(i) signaling with pertussis toxin restores cardiac function in heart failure associated with increased β(2)AR to G(i) coupling induced by removing PKA phosphorylation of the receptor and in GRK2 transgenic mice, indicating that enhanced phosphorylation of β(2)AR by GRK and resultant increase in G(i)-biased β(2)AR signaling play an important role in the development of heart failure.

Conclusions: Our data show that enhanced β(2)AR phosphorylation by GRK, in addition to PKA, leads the receptor to G(i)-biased signaling, which, in turn, contributes to the pathogenesis of heart failure, marking G(i)-biased β(2)AR signaling as a primary event linking upregulation of GRK to cardiac maladaptive remodeling, failure and cardiodepression.

Citing Articles

Status of β-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure.

Dhalla N, Bhullar S, Adameova A, Mota K, de Vasconcelos C Rev Cardiovasc Med. 2024; 24(9):264.

PMID: 39076390 PMC: 11270071. DOI: 10.31083/j.rcm2409264.


G protein-coupled receptor kinases in hypertension: physiology, pathogenesis, and therapeutic targets.

Zhang F, Armando I, Jose P, Zeng C, Yang J Hypertens Res. 2024; 47(9):2317-2336.

PMID: 38961282 PMC: 11374685. DOI: 10.1038/s41440-024-01763-y.


Sympatho-adrenergic mechanisms in heart failure: new insights into pathophysiology.

Du X Med Rev (2021). 2023; 1(1):47-77.

PMID: 37724075 PMC: 10388789. DOI: 10.1515/mr-2021-0007.


Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology.

Pozo M, Meredith G, Entcheva E Cells. 2022; 11(2).

PMID: 35053315 PMC: 8774228. DOI: 10.3390/cells11020200.


Cell therapy rescues aging-induced beta-1 adrenergic receptor and GRK2 dysfunction in the coronary microcirculation.

Rowe G, Tracy E, Beare J, LeBlanc A Geroscience. 2021; 44(1):329-348.

PMID: 34608562 PMC: 8811091. DOI: 10.1007/s11357-021-00455-6.


References
1.
Hu P, Zhang D, Swenson L, Chakrabarti G, Abel E, Litwin S . Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol. 2003; 285(3):H1261-9. DOI: 10.1152/ajpheart.00108.2003. View

2.
Xiao R . Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Sci STKE. 2001; 2001(104):re15. DOI: 10.1126/stke.2001.104.re15. View

3.
Oyama N, Urasawa K, Kaneta S, Sakai H, Saito T, Takagi C . Angiotensin converting enzyme inhibitors attenuated the expression of G-protein coupled receptor kinases in heart failure patients. Circ J. 2006; 70(3):362-3. DOI: 10.1253/circj.70.362. View

4.
Lloyd-Jones D, Adams R, Brown T, Carnethon M, Dai S, de Simone G . Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010; 121(7):948-54. DOI: 10.1161/CIRCULATIONAHA.109.192666. View

5.
Cohn J, Levine T, Olivari M, Garberg V, Lura D, Francis G . Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984; 311(13):819-23. DOI: 10.1056/NEJM198409273111303. View